IMNM Smart Money
Immunome, Inc.
1W: +4.7%
1M: -13.4%
3M: -18.8%
YTD: -9.8%
1Y: +19.6%
3Y: +115.0%
5Y: +3.0%
$18.77
+0.88 (+4.92%)
Pre-Market: $18.93 (+0.16, +0.83%)
Weekly Expected Move ±8.0%
$15
$17
$18
$19
$21
Credit Risk of going bust: lower than 84% of companies Debt: 0.2% of company value Bonds: none of note held by US funds details ▾
Of US companies ranked in the safest four tenths, about 1 in 3,500 filed for bankruptcy within a year (2020-2025).
If the stock fell to about $0.00 (down more than 99.9%), Immunome, Inc. would be worth roughly what it owes.
Total debt $4.6M against a stock market value of $2.21B.
Distance to default 11.03 (Merton model): prices to 2026-10-27, balance sheet 2026-06-30, debt counted $2.3M (short-term plus half of long-term), stock volatility 61.1%; Altman Z'' 11.56. A ranking and a back-test, not a forecast.
US fund filings (SEC N-PORT) show under $25M of this company's bonds, so there is no bond page. Its debt may be bank loans or privately placed. How these are computed.
If the stock fell to about $0.00 (down more than 99.9%), Immunome, Inc. would be worth roughly what it owes.
Total debt $4.6M against a stock market value of $2.21B.
Distance to default 11.03 (Merton model): prices to 2026-10-27, balance sheet 2026-06-30, debt counted $2.3M (short-term plus half of long-term), stock volatility 61.1%; Altman Z'' 11.56. A ranking and a back-test, not a forecast.
US fund filings (SEC N-PORT) show under $25M of this company's bonds, so there is no bond page. Its debt may be bank loans or privately placed. How these are computed.
Overview
News
Chart
Smart Money
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Dividends
Analysis
Technicals
Weather
Peers
ESG
Institutions
ETF Exposure
Dark Pool
Short Interest
Supply Chain
🏦 Institutional Activity
Latest: Q2 2026234
Institutions Holding
+5 vs prior
93.3%
Ownership
-2.62%
35
New
76
Increased
88
Reduced
28
Closed
👔 Insider Trades
25 records| Date | Name | Title | Type | Shares | Price | Value | Filing |
|---|---|---|---|---|---|---|---|
| 2026-09-11 | Higgins Jack | officer: chief scientific officer | G-Gift | 8,800 | $— | $0 | Filing |
| 2026-09-11 | Higgins Jack | officer: chief scientific officer | S-Sale | 13,200 | $25.32 | $334K | Filing |
| 2026-08-12 | Barchas Isaac | director | S-Sale | 11,048 | $27.25 | $301K | Filing |
| 2026-08-11 | Barchas Isaac | director | S-Sale | 62,291 | $26.23 | $1.6M | Filing |
| 2026-08-10 | Barchas Isaac | director | S-Sale | 10,125 | $26.07 | $264K | Filing |
| 2026-08-07 | Barchas Isaac | director | S-Sale | 15,248 | $26.06 | $397K | Filing |
| 2026-08-06 | Barchas Isaac | director | S-Sale | 20,840 | $26.06 | $543K | Filing |
| 2026-08-04 | Horn Kinney | officer: chief business officer | S-Sale | 90,616 | $25.09 | $2.3M | Filing |
| 2026-07-23 | Stoneman Sandra G. | officer: chief legal officer & gc | A-Grant/Award | 38,250 | $— | $0 | Filing |
| 2026-07-23 | Horn Kinney | officer: chief business officer | A-Grant/Award | 31,250 | $— | $0 | Filing |
| 2026-07-23 | Tsai Philip | officer: chief technical officer | A-Grant/Award | 38,250 | $— | $0 | Filing |
| 2026-07-23 | Higgins Jack | officer: chief scientific officer | A-Grant/Award | 38,250 | $— | $0 | Filing |
| 2026-07-23 | Rosett Max | officer: chief financial officer | A-Grant/Award | 47,250 | $— | $0 | Filing |
| 2026-07-23 | Lechleider Robert | officer: chief medical officer | A-Grant/Award | 54,000 | $— | $0 | Filing |
| 2026-07-23 | SIEGALL CLAY B | officer: president and ceo | A-Grant/Award | 180,000 | $— | $0 | Filing |
| 2026-07-07 | Horn Kinney | officer: chief business officer | S-Sale | 1,092 | $25.00 | $27K | Filing |
| 2026-07-07 | Barchas Isaac | director | S-Sale | 16,906 | $24.20 | $409K | Filing |
| 2026-07-06 | Barchas Isaac | director | S-Sale | 83,094 | $24.11 | $2.0M | Filing |
| 2026-07-02 | Barchas Isaac | director | S-Sale | 75,665 | $22.35 | $1.7M | Filing |
| 2026-07-02 | Lechleider Robert | officer: chief medical officer | S-Sale | 16,072 | $23.44 | $377K | Filing |
| 2026-07-02 | Lechleider Robert | officer: chief medical officer | S-Sale | 16,214 | $22.76 | $369K | Filing |
| 2026-07-02 | Lechleider Robert | officer: chief medical officer | S-Sale | 22,714 | $21.95 | $499K | Filing |
| 2026-07-02 | Barchas Isaac | director | S-Sale | 24,335 | $23.33 | $568K | Filing |
| 2026-06-30 | Barchas Isaac | director | S-Sale | 101,050 | $21.12 | $2.1M | Filing |
| 2026-06-25 | Lechleider Robert | officer: chief medical officer | S-Sale | 14,420 | $20.66 | $298K | Filing |
🏛️ Congressional Trades
0 records| Date | Politician | Chamber | Type | Amount | Filing |
|---|---|---|---|---|---|
| No congressional trades found | |||||
🏦 Top Institutional Holders
20 holders| Holder | Shares | Value | Date Reported | Filing | |
|---|---|---|---|---|---|
| FMR LLC | 16,987,553 | $360M | +17,599 | 2026-06-30 | Filing |
| BlackRock, Inc. | 8,805,492 | $187M | +636,818 | 2026-06-30 | Filing |
| STATE STREET CORP | 5,494,625 | $116M | +94,724 | 2026-06-30 | Filing |
| WELLINGTON MANAGEMENT GROUP LLP | 5,210,216 | $110M | +478,239 | 2026-06-30 | Filing |
| Redmile Group, LLC | 4,911,590 | $104M | -647,295 | 2026-06-30 | Filing |
| PRIMECAP MANAGEMENT CO/CA | 4,581,431 | $97M | -206,800 | 2026-06-30 | Filing |
| VANGUARD CAPITAL MANAGEMENT LLC | 4,551,289 | $96M | +121,592 | 2026-06-30 | Filing |
| Driehaus Capital Management LLC | 4,346,139 | $92M | +246,238 | 2026-06-30 | Filing |
| ENAVATE SCIENCES GP, LLC | 3,613,799 | $77M | — | 2026-06-30 | Filing |
| GEODE CAPITAL MANAGEMENT, LLC | 2,754,889 | $58M | +194,225 | 2026-06-30 | Filing |
| MORGAN STANLEY | 2,407,942 | $51M | -433,647 | 2026-06-30 | Filing |
| SILVERARC CAPITAL MANAGEMENT, LLC | 2,017,009 | $43M | +166,731 | 2026-06-30 | Filing |
| JPMORGAN CHASE & CO | 1,848,548 | $39M | -929,288 | 2026-06-30 | Filing |
| Sofinnova Investments, Inc. | 1,720,316 | $36M | +18,412 | 2026-06-30 | Filing |
| READYSTATE ASSET MANAGEMENT LP | 1,605,820 | $34M | +303,958 | 2026-06-30 | Filing |
| GOLDMAN SACHS GROUP INC | 1,512,489 | $32M | +411,013 | 2026-06-30 | Filing |
| VANGUARD PORTFOLIO MANAGEMENT LLC | 1,348,979 | $29M | +342,004 | 2026-06-30 | Filing |
| PRINCIPAL FINANCIAL GROUP INC | 1,347,358 | $29M | -29,509 | 2026-06-30 | Filing |
| BNP PARIBAS ASSET MANAGEMENT Holding S.A | 1,250,275 | $26M | +152,439 | 2026-06-30 | Filing |
| Woodline Partners LP | 1,000,398 | $21M | -575,000 | 2026-06-30 | Filing |